Eran Broshy insider trades: Theravance Biopharma (TBPH) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Eran reports to the SEC





Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 26, 2025 | TBPH | ↓ Sell10b5-1 | 29,501 | $20.00 | $590K | Direct | Dec 1, 2025 (5d) |
| Nov 11, 2025 | TBPH | ↓ Sell10b5-1 | 59,000 | $18.11 | $1.1M | Direct | Nov 13, 2025 (2d) |
| Aug 22, 2023 | CERT | ↑ Buy | 5,000 | $15.81 | $79K | Direct | Aug 23, 2023 (1d) |
| Feb 23, 2017 | MGLN | ↓ Sell | 4,867 | $80.00 | $389K | Direct | Feb 27, 2017 (4d) |
| Dec 8, 2016 | MGLN | ↓ Sell | 2,433 | $75.00 | $182K | Direct | Dec 12, 2016 (4d) |
| Jun 15, 2010 | VTIV | ↑ Buy | 22,806 | $25.15 | $574K | Direct | Jun 17, 2010 (2d) |
| Aug 12, 2008 | VTIV | ↑ Buy | 14,000 | $18.04 | $253K | Direct | Aug 14, 2008 (2d) |
| Jul 17, 2007 | VTIV | ↓ Sell | 43,938 | $38.11 | $1.7M | Direct | Jul 18, 2007 (1d) |
| Jul 10, 2007 | VTIV | ↓ Sell | 36,000 | $37.81 | $1.4M | Direct | Jul 10, 2007 (0d) |
| Jun 14, 2007 | VTIV | ↓ Sell | 54,000 | $37.25 | $2.0M | Direct | Jun 18, 2007 (4d) |
| May 23, 2007 | VTIV | ↓ Sell | 43,000 | $37.75 | $1.6M | Direct | May 24, 2007 (1d) |
| May 15, 2007 | VTIV | ↓ Sell | 47,000 | $38.37 | $1.8M | Direct | May 16, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TBPH insiders
Open-market trades in the last 12 months
About Eran Broshy's insider trades
Eran Broshy is an insider at Theravance Biopharma (TBPH). Since May 15, 2007, Eran has reported 3 open-market purchases worth $905K and 9 sales worth $10.7M on SEC Form 4. In the last 12 months: 2 sales ($1.7M).
2 sales (15% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (55 filings), option exercises (11 filings), gifts (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TBPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.